158 related articles for article (PubMed ID: 9001868)
1. The dynamic interplay of malignant and benign T cells in cutaneous T-cell lymphoma.
Herrick C; Heald P
Dermatol Clin; 1997 Jan; 15(1):149-57. PubMed ID: 9001868
[TBL] [Abstract][Full Text] [Related]
2. The immunopathogenesis of cutaneous T-cell lymphoma.
Rook AH; Heald P
Hematol Oncol Clin North Am; 1995 Oct; 9(5):997-1010. PubMed ID: 8522492
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large cell non-Hodgkin's lymphoma, CD30+, T-cell phenotype.
Gruson LM; Latkowski JA
Dermatol Online J; 2005 Dec; 11(4):17. PubMed ID: 16403389
[TBL] [Abstract][Full Text] [Related]
5. Malignant T cells activate endothelial cells via IL-17 F.
Lauenborg B; Litvinov IV; Zhou Y; Willerslev-Olsen A; Bonefeld CM; Nastasi C; Fredholm S; Lindahl LM; Sasseville D; Geisler C; Wasik MM; Krejsgaard T; Gjerdrum LMR; Iversen L; Odum N; Woetmann A
Blood Cancer J; 2017 Jul; 7(7):e586. PubMed ID: 28731459
[No Abstract] [Full Text] [Related]
6. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis and therapy of cutaneous T cell lymphoma.
Kim EJ; Hess S; Richardson SK; Newton S; Showe LC; Benoit BM; Ubriani R; Vittorio CC; Junkins-Hopkins JM; Wysocka M; Rook AH
J Clin Invest; 2005 Apr; 115(4):798-812. PubMed ID: 15841167
[TBL] [Abstract][Full Text] [Related]
8. Photopheresis for cutaneous T cell lymphoma.
Heald PW
Ann N Y Acad Sci; 1991 Dec; 636():171-7. PubMed ID: 1793207
[No Abstract] [Full Text] [Related]
9. Primary cutaneous CD8+ T-cell lymphoma masquerading as acral vascular syndrome.
Le Loarer F; Barete S; Vallat L; Carre D; El Amarti R; Torres-Cabala C; Cacoub P; Sene D; Courville P; Bravard P
Acta Derm Venereol; 2014 May; 94(3):317-9. PubMed ID: 23995595
[No Abstract] [Full Text] [Related]
10. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens.
Agbay RL; Torres-Cabala CA; Patel KP; Merril ED; Duvic M; Quesada A; Prieto VG; Aung PP; Loghavi S; Young KH; Hu S; Ferrufino-Schmidt MC; Tetzlaff M; Li S; Medeiros LJ; Miranda RN
Am J Surg Pathol; 2017 Apr; 41(4):431-445. PubMed ID: 28248813
[TBL] [Abstract][Full Text] [Related]
11. [Management of cutaneous lymphoma ].
Beylot-Barry M; Battistella M
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
[No Abstract] [Full Text] [Related]
12. CD8+ cutaneous T-cell lymphoma.
Agnarsson BA; Vonderheid EC; Kadin ME
Am J Dermatopathol; 1991 Dec; 13(6):628-9. PubMed ID: 1805657
[No Abstract] [Full Text] [Related]
13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
14. Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.
Herrmann JJ; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):819-22. PubMed ID: 7523465
[No Abstract] [Full Text] [Related]
15. Graft-versus-lymphoma effect.
Richard C; Bermúdez A; Izu R
Br J Haematol; 2010 Apr; 149(2):166. PubMed ID: 20015300
[No Abstract] [Full Text] [Related]
16. Management of cutaneous T-cell lymphoma.
Duhovic C; Child F; Wain EM
Clin Med (Lond); 2012 Apr; 12(2):160-4. PubMed ID: 22586794
[No Abstract] [Full Text] [Related]
17. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a.
Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T-cell lymphoma.
Perez A; Whittaker S
Br J Hosp Med (Lond); 2006 Apr; 67(4):178-83. PubMed ID: 16681303
[No Abstract] [Full Text] [Related]
19. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
Horna P; Deaver DM; Qin D; Moscinski LC; Sotomayor EM; Glass LF; Sokol L
J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
[TBL] [Abstract][Full Text] [Related]
20. Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20.
Frings VG; Roth S; Riedmiller AL; Schäfer K; Goebeler M; Rosenwald A; Geissinger E; Wobser M
Acta Derm Venereol; 2017 Apr; 97(4):534-536. PubMed ID: 27840885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
